# Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A0107

> **NCT00149916** · PHASE3 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 139 (actual)

## Conditions studied

- Renal Transplant

## Interventions

- **DRUG:** Mycophenolate sodium (enteric coated)

## Key facts

- **NCT ID:** NCT00149916
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-04
- **Primary completion:** 2004-04
- **Final completion:** —
- **Target enrollment:** 139 (ACTUAL)
- **Last updated:** 2011-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00149916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00149916, "Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A0107". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00149916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*